IP Verse

Swan patent opposition analysis

The comprehensive analysis of Swan opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Swan

Stay updated with the latest patent oppositions filed by Swan

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3456192
Antibody Producing Non-Human MammalsMERUSJun 3, 2026KYMAB
EP4074331
Compositions And Methods For Internalizing EnzymesREGENERON PHARMACEUTICALSJun 3, 2026SANOFI
EP4349407
5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Major DepressionGH RESEARCH IRELANDJan 9, 2026STRAWMAN
EP3927338
Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Use In Treating Mental DisordersGH RESEARCH IRELANDJul 9, 2025STRAWMAN
EP3770258
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEApr 16, 2025CMS CAMERON MCKENNA NABARRO OLSWANG
EP3522732
Methods And Systems For Generating A Sterilized Human Milk ProductLACTALOGICSJan 23, 2025STRAWMAN
EP3628319
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
EP3927337
5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating DepressionGH RESEARCH IRELANDNov 13, 2024STRAWMAN
EP2849802
Treatment Of Amd Using Aav Sflt-1AVALANCHE AUSTRALIASep 19, 2024STRAWMAN
EP3542790
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024CMS CAMERON MCKENNA NABARRO OLSWANG

Top clients of Swan

Top companies who are the clients of Swan

CompanyTotal
STRAWMAN14
CMS CAMERON MCKENNA NABARRO OLSWANG9
KYMAB8
TESLA GERMANY3
WITHERS & ROGERS LLPJONES NICHOLAS WRIGHT HOWARD WALLIN NICHOLAS2
SANOFI2
SILENCE THERAPEUTICS2
SNIPR BIOME1
POHLMAN1
NESTLE1